NIIMBL's Projects and Programs

Both projects and programs are opportunities for direct member involvement to help benefit the biopharmaceutical manufacturing community, but they have some key complementary differences.

Project call program

  • Broad solicitation of projects from NIIMBL members on technical and workforce topics
  • NIIMBL committees provide recommendations for topic areas
  • All NIIMBL members can participate

NIIMBL-led programs

  • Specific coordinated projects around a strategic technical theme
  • Defined by member program participants, led by NIIMBL Program Leads and Steering Team
  • Participation is based on membership tier

Workforce programs

  • Allow academia and industry to work together, foster connections, build skills, and connect qualified candidates with job opportunities
  • Can include programs for students to gain insight into the biopharmaceutical industry and possible careers

Project call program

NIIMBL proudly funds projects that accelerate technology advancement and help improve the skills of our workforce.
  • Project calls are issued approximately annually
  • Priority topic areas for technical and/or workforce development proposals are member-driven and industry-led
  • Completed projects have affected real change in areas throughout the biopharmaceutical ecosystem, including:
    • Reducing costs and measurement time with real-time monitoring in bioreactors
    • Saving millions in facility construction costs for downstream processing
    • Developing software and hardware tools for use by the entire ecosystem in R&D labs
    • Significant cost savings in the manufacture of cytokines for cell growth

Number of Funded Projects

As of June 30, 2024

Solicitations

Current opportunities

We achieve our mission through an RFx process that aims to advance technical and workforce development projects:

  • Request for Proposals
    (RFP): A solicitation sent to the entire NIIMBL community that is to result in funding of activities
  • Request for Information
    (RFI): An open invitation for organizations to share information; not directly associated with funding
  • Request for Applications
    (RFA): A focused solicitation to particular organizations to submit an application intended to result in funding of activities

RFP: Project Call 10.1
RFA: NIIMBL eXperience for Educators
RFA: Faculty Fellows

RFP: Project Call 10.1

NIIMBL is pleased to announce Project Call 10.1, with member- driven and industry-led priority topic areas for technical development proposals.

Technology Topics:

  • Intelligent Biomanufacturing Through Artificial Intelligence, Digitalization, and Advanced Process Control
  • Advanced Process Analytics, Product Quality, and Real-Time Manufacturing Control
  • Advanced Manufacturing Platforms and Process Intensification
  • Platform Technologies for Emerging and Next-Generation Biotherapeutics
  • Transformative Platform Technologies for the Future Biomanufacturing Enterprise

Workforce Development Topics:

  • Catalyzing Cross‑Regional Workforce Development Solutions
  • Workforce Development for Advanced Therapeutic Modalities
  • Developing a Digitally Fluent Biomanufacturing Workforce

Learn More

RFA: NIIMBL eXperience for Educators

NIIMBL is pleased to issue a Request for Applications (RFA) for the NIIMBL eXperience for Educators Program.

The NIIMBL eXperience for Educators is a two-day immersive event designed to introduce K–12 educators and counselors to the biopharmaceutical manufacturing industry. Through hands-on activities, industry engagement, and networking, participants will gain valuable insights into career opportunities and educational pathways for their students. 

This RFA seeks applicants to host a NIIMBL eXperience for Educators Program. The goal is to equip K-12 educators with foundational knowledge of the biopharmaceutical industry so they can better inform and inspire their students.

The application deadline is October 15, 2026.

Learn more.

RFA: Faculty Fellows

NIIMBL is pleased to announce the pilot of a faculty sabbatical in industry program. The NIIMBL Faculty Fellows program provides financial support for faculty or instructional staff at universities and community colleges to pursue a sabbatical either at an industry member (Tier 1 or Tier 2) or at NIIMBL’s Headquarters (NIIMBL HQ) in Delaware to support NIIMBL-led projects.

Objectives

  • Create an engaged community of academics that can work collaboratively and effectively with industry and represent a variety of disciplines, backgrounds, and institutions
  • Gain valuable experience and exposure to state-of-the-art biopharmaceutical manufacturing, learn about real-world industry challenges, seed new industry-academic partnerships, and strengthen the overall member community


Requirements

  • Up to 12-month sabbatical period (12 months is the preferred duration)
  • Maximum total budget of $200,000

Learn more about the Faculty Fellows Program

RFP: Project Call 10.1arrow down

RFP: Project Call 10.1

NIIMBL is pleased to announce Project Call 10.1, with member- driven and industry-led priority topic areas for technical development proposals.

Technology Topics:

  • Intelligent Biomanufacturing Through Artificial Intelligence, Digitalization, and Advanced Process Control
  • Advanced Process Analytics, Product Quality, and Real-Time Manufacturing Control
  • Advanced Manufacturing Platforms and Process Intensification
  • Platform Technologies for Emerging and Next-Generation Biotherapeutics
  • Transformative Platform Technologies for the Future Biomanufacturing Enterprise

Workforce Development Topics:

  • Catalyzing Cross‑Regional Workforce Development Solutions
  • Workforce Development for Advanced Therapeutic Modalities
  • Developing a Digitally Fluent Biomanufacturing Workforce

Learn More

RFA: NIIMBL eXperience for Educatorsarrow down

RFA: NIIMBL eXperience for Educators

NIIMBL is pleased to issue a Request for Applications (RFA) for the NIIMBL eXperience for Educators Program.

The NIIMBL eXperience for Educators is a two-day immersive event designed to introduce K–12 educators and counselors to the biopharmaceutical manufacturing industry. Through hands-on activities, industry engagement, and networking, participants will gain valuable insights into career opportunities and educational pathways for their students. 

This RFA seeks applicants to host a NIIMBL eXperience for Educators Program. The goal is to equip K-12 educators with foundational knowledge of the biopharmaceutical industry so they can better inform and inspire their students.

The application deadline is October 15, 2026.

Learn more.

RFA: Faculty Fellowsarrow down

RFA: Faculty Fellows

NIIMBL is pleased to announce the pilot of a faculty sabbatical in industry program. The NIIMBL Faculty Fellows program provides financial support for faculty or instructional staff at universities and community colleges to pursue a sabbatical either at an industry member (Tier 1 or Tier 2) or at NIIMBL’s Headquarters (NIIMBL HQ) in Delaware to support NIIMBL-led projects.

Objectives

  • Create an engaged community of academics that can work collaboratively and effectively with industry and represent a variety of disciplines, backgrounds, and institutions
  • Gain valuable experience and exposure to state-of-the-art biopharmaceutical manufacturing, learn about real-world industry challenges, seed new industry-academic partnerships, and strengthen the overall member community


Requirements

  • Up to 12-month sabbatical period (12 months is the preferred duration)
  • Maximum total budget of $200,000

Learn more about the Faculty Fellows Program

Past opportunities

American rescue plan

NIIMBL funded 32 coronavirus response projects to multiple organizations across the United States.

Project Call 8.1

NIIMBL awarded 11 new member-led technology, workforce development, and Global Health Fund projects with a value of ~$11.2 million.

Learn about more past funding opportunities

Case studies

December 2023

Single-use Modules for Continuous Removal of Antibody Fragments

LigaTrap Technologies, LLC, Merck & Co., Inc., MilliporeSigma/EMD Serono, North Carolina State University, Rensselaer Polytechnic Institute

PDF and arrow icon

August 2023

A New Generation of High-efficiency HVAC Filters that Can Be Used with Existing Infrastructure to Stop the Spread of Coronavirus Through Recirculation of Air

North Carolina State University

PDF and arrow icon

August 2023

Development of a Thermo-tolerant, Multidose, Egg-produced, Vector-based Coronavirus Vaccine

PATH Center for Vaccines Innovation & Access

PDF and arrow icon

August 2023

Development of Scalable, Thermostable, Spray Dried Vaccine Formulations Applicable for Coronavirus Vaccines

Fraunhofer USA

PDF and arrow icon

November 2022

Noninvasive PAT for Aluminum-adjuvanted Vaccines

Merck & Co., Inc., Pfizer, Inc., University of Maryland Baltimore

PDF and arrow icon

September 2022

Specific Detection of Infected Cells Using Optical Drag-Tags in Laser Force Cytology

Carnegie Mellon University, LumaCyte, Merck & Co., Inc., Rensselaer Polytechnic Institute

PDF and arrow icon

NIIMBL-led programs

NIIMBL-Led Programs accelerate progress around a strategic technical theme to benefit the relevant biopharmaceutical manufacturing community.
Through these programs, NIIMBL is committed to finding solutions to key biopharmaceutical manufacturing challenges that will push the limits of what is currently possible and accelerate the speed at which we manufacture therapies.

Impacts for participants – and the entire biopharmaceutical ecosystem

  • Flexible solutions and assets that will catalyze advances across the biopharmaceutical manufacturing field, solving problems that are difficult or impossible to solve individually
  • Core standardized platforms, tools, and processes that all participants can apply to their own future projects—saving time, effort, and money
  • Interdisciplinary, cross-organizational insights that will provide industrially-relevant direction and inform strategic, specific outreach to the NIIMBL community (e.g. RFI, RFA, RFP) 

Why participate in NIIMBL-led programs?

  • Build your organization’s authority as, and connection to, industry leadership
  • Ensure the strategic direction of the industry aligns with your organization’s interests
  • Access your organization’s current state relative to others in the space
  • Access and leverage real-time “market research” and advanced technologies from a broad cross-section of the community to inform your own strategic direction
  • Help your employees/colleagues build expertise, industry awareness, and leadership skills

Big data
Process intensification
Preventive Medical Countermeasures
Viral vector manufacturing & analytics

Big data

Mission
Accelerate the development and adoption of data-driven innovation and standards to increase the speed and resilience of biopharmaceutical manufacturing.

Vision
Data-driven technologies optimize the productivity of biopharmaceutical manufacturing and accelerate the delivery of high-quality medicines to patients.

Learn more about Big Data Program

Process intensification

Mission
The Process Intensification Program accelerates innovative, flexible, and sustainable biopharmaceutical manufacturing by advancing intensified technologies through strong industry–academic collaboration.

Vision
To create a seamlessly integrated, highly intensified, and digitally connected manufacturing ecosystem that enables faster, more reliable, and sustainable delivery of lifechanging therapies.

Learn more about Process Intensification Program

Preventive Medical Countermeasures

Mission
Enable rapid, consistent, and scalable manufacturing of emerging preventive medical countermeasure platforms by advancing analytical understanding, improving process robustness, and creating data and tools that support industry adoption.

Vision
A biopharmaceutical ecosystem equipped with platform ready analytics, harmonized practices, and adaptable manufacturing approaches that accelerate time to clinic and time to market for high quality preventive medical countermeasures.

Learn more about the Preventive Medical Countermeasure  Program

Viral vector manufacturing & analytics

Mission
Develop and make broadly available a robust, economically viable, shared-access platform for the technical development, manufacturing, and characterization of AAV-based gene therapy vectors. Ensure that workforce training for this platform can integrate into existing curriculum or training models to encourage adoption, and integrate improvements into the platform based on feedback from these training programs.

Vision
A gene-based therapeutics industry capable of serving patients across the full spectrum of unmet needs—from prevalent indications to ultra-rare diseases—that has access to high-quality viral vectors without cost or speed limitations.

Learn more about Viral Vectors Program

Big dataarrow down

Big data

Mission
Accelerate the development and adoption of data-driven innovation and standards to increase the speed and resilience of biopharmaceutical manufacturing.

Vision
Data-driven technologies optimize the productivity of biopharmaceutical manufacturing and accelerate the delivery of high-quality medicines to patients.

Learn more about Big Data Program

Process intensificationarrow down

Process intensification

Mission
The Process Intensification Program accelerates innovative, flexible, and sustainable biopharmaceutical manufacturing by advancing intensified technologies through strong industry–academic collaboration.

Vision
To create a seamlessly integrated, highly intensified, and digitally connected manufacturing ecosystem that enables faster, more reliable, and sustainable delivery of lifechanging therapies.

Learn more about Process Intensification Program

Preventive Medical Countermeasuresarrow down

Preventive Medical Countermeasures

Mission
Enable rapid, consistent, and scalable manufacturing of emerging preventive medical countermeasure platforms by advancing analytical understanding, improving process robustness, and creating data and tools that support industry adoption.

Vision
A biopharmaceutical ecosystem equipped with platform ready analytics, harmonized practices, and adaptable manufacturing approaches that accelerate time to clinic and time to market for high quality preventive medical countermeasures.

Learn more about the Preventive Medical Countermeasure  Program

Viral vector manufacturing & analyticsarrow down

Viral vector manufacturing & analytics

Mission
Develop and make broadly available a robust, economically viable, shared-access platform for the technical development, manufacturing, and characterization of AAV-based gene therapy vectors. Ensure that workforce training for this platform can integrate into existing curriculum or training models to encourage adoption, and integrate improvements into the platform based on feedback from these training programs.

Vision
A gene-based therapeutics industry capable of serving patients across the full spectrum of unmet needs—from prevalent indications to ultra-rare diseases—that has access to high-quality viral vectors without cost or speed limitations.

Learn more about Viral Vectors Program

Workforce programs

NIIMBL is committed to helping the biopharmaceutical industry solve workforce shortages by creating awareness of biopharmaceutical careers and fostering industry and academic connections.

NIIMBL eXperience

The NIIMBL eXperience is a hands-on, expenses-paid week-long program for college first years and sophomores to gain real-world insight into career possibilities in biopharmaceutical manufacturing.

It’s also an opportunity for NIIMBL academic or non-profit Member organizations to serve as regional lead organizations that will plan, recruit students, and run a NIIMBL eXperience program in their region.

Faculty fellows

The NIIMBL Faculty Fellows program provides financial support for faculty or instructional staff at universities and community colleges to pursue a sabbatical either at an industry member or at NIIMBL’s Headquarters in Delaware to support NIIMBL-led projects.

Become a member

We offer a variety of membership options that give you the flexibility to choose your organization’s level of engagement based on technology interests and priorities.